Under the accessibility and affordability amendment from Senator Sharif Street last month, patients 21 and older would have been able to cultivate up to five plants.
That would’ve marked a notable expansion of the state’s existing program through which patients must purchase from publicly-traded out-of-state corporations at arguably the highest prices in the nation.
“It’s disturbing that Senator Laughlin is willing to pass laws benefiting the corporate industry while jeopardizing the livelihood of his constituents. In Pennsylvania, patients are still being thrown in prison for growing their own medicine. Families are being torn apart because of elected officials like Senator Dan Laughlin,” said Marty Kennedy, a medical cannabis patient from Erie County.
Republicans support arresting parents who consume cannabis.
— The Cannabis Patriot 🌱 🇺🇸 (@PLegalization) January 2, 2023
This in turns destroys families and puts them in poverty.
All in the name of nanny-state, “law and order” tyranny. https://t.co/g4q60ou54G
And we waited for two years to see something. Anything. What did we get?
— Pittsburghatory (@pittsburghatory) February 7, 2023
1. Moldy meds being approved
2. Dangerous pesticides being approved
3. Large MSOs narrow competition and reduce total number of licenses
4. Patients still getting DUIs for medicine used a day prior.
Senate Members tabled the amendment in a party-line vote of 29-21. 'Yes' votes like Senator Laughlin's supported blocking access for patients: